Aurisco Pharmaceutical Co Ltd Tangible Net Worth Ratio
Aurisco Pharmaceutical Co Ltd tangible net worth ratio. Aurisco Pharmaceutical Co Ltd (605116) has a Tangible Net Worth Ratio of 93.4% as of June 2025. This metric is calculated by deducting intangible assets (CN¥159.74 Million) from net assets (CN¥2.43 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how leveraged is Aurisco Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Aurisco Pharmaceutical Co Ltd (2016–2024)
Tangible net worth ratio of Aurisco Pharmaceutical Co Ltd from 2016 to 2024. This chart shows how Aurisco Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 93.4%, reflecting net assets of CN¥2.43 Billion with intangible assets of CN¥159.74 Million CNY. See Aurisco Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Aurisco Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2016–2024)
Aurisco Pharmaceutical Co Ltd tangible net worth ratio by year from 2016 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Aurisco Pharmaceutical Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Aurisco Pharmaceutical Co Ltd market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 93.1% | CN¥2.33 Billion | CN¥161.46 Million | CN¥3.88 Billion | ▼ -0.8 pp |
| 2023 | 93.8% | CN¥1.97 Billion | CN¥121.40 Million | CN¥2.57 Billion | ▲ +1.1 pp |
| 2022 | 92.7% | CN¥1.68 Billion | CN¥122.71 Million | CN¥2.03 Billion | ▼ -4.6 pp |
| 2021 | 97.3% | CN¥1.51 Billion | CN¥40.42 Million | CN¥1.72 Billion | ▲ +0.3 pp |
| 2020 | 97.0% | CN¥1.39 Billion | CN¥41.94 Million | CN¥1.53 Billion | ▲ +1.3 pp |
| 2019 | 95.6% | CN¥977.28 Million | CN¥42.70 Million | CN¥1.10 Billion | ▼ -0.2 pp |
| 2018 | 95.8% | CN¥787.54 Million | CN¥32.71 Million | CN¥920.70 Million | ▲ +0.7 pp |
| 2017 | 95.1% | CN¥683.95 Million | CN¥33.26 Million | CN¥816.38 Million | ▲ +0.9 pp |
| 2016 | 94.3% | CN¥589.81 Million | CN¥33.83 Million | CN¥781.82 Million | — |